M L71 Pill - pink round, 6mm
Pill with imprint M L71 is Pink, Round and has been identified as Letrozole 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M L71
Letrozole
- Imprint
- M L71
- Strength
- 2.5 mg
- Color
- Pink
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2071 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
D&C Red No. 27,
FD&C Blue No. 2,
FD&C Red No. 40,
hypromelloses,
lactose anhydrous,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
corn starch,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "M L71"
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (347)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.